RT @susanmsmith: Need to exclude various factors before can really identify treatment resistant hypertension from @nuigalway @pmrycaretrial…
RT @susanmsmith: Need to exclude various factors before can really identify treatment resistant hypertension from @nuigalway @pmrycaretrial…
RT @susanmsmith: Need to exclude various factors before can really identify treatment resistant hypertension from @nuigalway @pmrycaretrial…
RT @susanmsmith: Need to exclude various factors before can really identify treatment resistant hypertension from @nuigalway @pmrycaretrial…
RT @susanmsmith: Need to exclude various factors before can really identify treatment resistant hypertension from @nuigalway @pmrycaretrial…
RT @susanmsmith: Need to exclude various factors before can really identify treatment resistant hypertension from @nuigalway @pmrycaretrial…
Need to exclude various factors before can really identify treatment resistant hypertension from @nuigalway @pmrycaretrials1- Important for GPs making these decisions daily @ICGPnews @HRBPrimaryCare https://t.co/dN5wYBUZmY
RT @BJGPjournal: When issues of adherence, dosage and white coat hypertension are addressed, the true prevalence of treatment-resistant hyp…
RT @BJGPjournal: When issues of adherence, dosage and white coat hypertension are addressed, the true prevalence of treatment-resistant hyp…
RT @BJGPjournal: When issues of adherence, dosage and white coat hypertension are addressed, the true prevalence of treatment-resistant hyp…
RT @DurandHannah: Our prevalence study of resistant #hypertension (considering pseudo-resistance & morbidity) is in the current @BJGPjourna…
RT @BJGPjournal: When issues of adherence, dosage and white coat hypertension are addressed, the true prevalence of treatment-resistant hyp…
RT @BJGPjournal: When issues of adherence, dosage and white coat hypertension are addressed, the true prevalence of treatment-resistant hyp…
Prevalence of treatment-resistant hypertension after considering pseudo-resistance and morbidity: a cross-sectional study in Irish primary care https://t.co/um9gqPdAc3
When issues of adherence, dosage and white coat hypertension are addressed, the true prevalence of treatment-resistant hypertension in general practice is about 3% https://t.co/iBRGpnBbpD
RT @DurandHannah: Our prevalence study of resistant #hypertension (considering pseudo-resistance & morbidity) is in the current @BJGPjourna…
Our prevalence study of resistant #hypertension (considering pseudo-resistance & morbidity) is in the current @BJGPjournal issue on #CVD. Considering pseudo-resistance (#adherence) may be sufficient in the majority of RH cases @pmrycaretrials1 https://
RT @DurandHannah: In our prevalence study of resistant #hypertension in primary care, applying @American_Heart @escardio criteria incl. a t…
RT @DurandHannah: In our prevalence study of resistant #hypertension in primary care, applying @American_Heart @escardio criteria incl. a t…
In our prevalence study of resistant #hypertension in primary care, applying @American_Heart @escardio criteria incl. a threshold of adequate medication #adherence reduced prevalence of RH to just 3%. Need to address poor antihypertensive adherence! https:
RT @DurandHannah: Latest publication from our resistant #hypertension study is online now! "Prevalence of treatment-resistant hypertension…
RT @DurandHannah: Latest publication from our resistant #hypertension study is online now! "Prevalence of treatment-resistant hypertension…
RT @LiamGGlynn: Great work Peter and all the team!! https://t.co/wubDQjO2z5
RT @DurandHannah: Latest publication from our resistant #hypertension study is online now! "Prevalence of treatment-resistant hypertension…
RT @DurandHannah: Latest publication from our resistant #hypertension study is online now! "Prevalence of treatment-resistant hypertension…
Great work Peter and all the team!! https://t.co/wubDQjO2z5
RT @DurandHannah: Latest publication from our resistant #hypertension study is online now! "Prevalence of treatment-resistant hypertension…
RT @DurandHannah: Latest publication from our resistant #hypertension study is online now! "Prevalence of treatment-resistant hypertension…
RT @DurandHannah: Latest publication from our resistant #hypertension study is online now! "Prevalence of treatment-resistant hypertension…
RT @DurandHannah: Latest publication from our resistant #hypertension study is online now! "Prevalence of treatment-resistant hypertension…
RT @DurandHannah: Latest publication from our resistant #hypertension study is online now! "Prevalence of treatment-resistant hypertension…
Latest publication from our resistant #hypertension study is online now! "Prevalence of treatment-resistant hypertension after considering pseudo-resistance and morbidity: a cross-sectional study in Irish primary care" @BJGPjournal @pmrycaretrials1 https: